Cause of death, by non-communicable diseases, male in Turkey
Turkey: Cause of death, by non-communicable diseases, male was 65.7% in 2021. ▼ Falling
Cause of death, by non-communicable diseases, male in Turkey, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total male deaths.
Analysis
In 2021, cause of death, by non-communicable diseases, male in Turkey stood at 65.7%. That is the lowest value across all 6 years on record.
The figure is down 12.8% on the previous year and down 24.7% over ten years.
Over the whole period, cause of death, by non-communicable diseases, male in Turkey peaked at 88.1% in 2019 and was at its lowest, 65.7%, in 2021.
Turkey ranks 73rd of 185 countries on this measure, in the middle of the range.
Cause of death, by non-communicable diseases, male in Turkey, year by year
| Year | % of total male deaths | Change |
|---|---|---|
| 2000 | 81.8% | — |
| 2010 | 87.2% | +6.7% |
| 2015 | 86.7% | -0.7% |
| 2019 | 88.1% | +1.6% |
| 2020 | 75.4% | -14.4% |
| 2021 | 65.7% | -12.8% |
Turkey compared with similar countries
- Turkey's 65.7% is above the median for upper middle income countries, which is 59.4%, 1.1× the median. (55 countries reporting)
- Turkey's 65.7% is below the median for Europe & Central Asia, which is 75.7%, 87% of the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 81.8% | 81.8% | 81.8% | 1 |
| 2010s | 87.3% | 86.7% | 88.1% | 3 |
| 2020s | 70.6% | 65.7% | 75.4% | 2 |
Countries ranked near Turkey
- 70 United Arab Emirates 66.9% compare
- 71 Solomon Islands 66.7% compare
- 72 North Macedonia 66.1% compare
- 74 Slovakia 65.5% compare
- 75 Antigua and Barbuda 64.8% compare
- 76 Fiji 64.5% compare
More health data for Turkey
- Un projection of annual infant deaths, annual growth rate -1.72 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5275 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,582 deaths per 1,000 people (2090)
- Number of infants who die before age 1 858 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 1 (2025)
- Population ages 00-04, female, annual growth rate -3.16 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0298 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.94 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, male in Turkey?
- Cause of death, by non-communicable diseases, male in Turkey was 65.7% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, male recorded in Turkey?
- The highest recorded value was 88.1% in 2019.
- What is the lowest cause of death, by non-communicable diseases, male recorded in Turkey?
- The lowest recorded value was 65.7% in 2021.
- How does Turkey rank for cause of death, by non-communicable diseases, male?
- Turkey ranks 73rd out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, male rising or falling in Turkey?
- Over the last ten years it is down 24.7%. The long-run trend across the full record is falling.
- Where does this Turkey data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, male (% of total male deaths). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of male deaths ages due to non-communicable diseases divided by number of all male deaths ages, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.